BELLUS HEALTH INC (BLU) Stock Analyst Ratings
NASDAQ:BLU - Nasdaq - CA07987C2040 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 76% to BLU. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.39. This target is 4.44% above the current price.
BLU was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BLU.
In the previous month the buy percentage consensus was at a similar level.
BLU was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-15 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-04-19 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-04-19 | Jefferies | Downgrade | Buy -> Hold |
| 2023-04-18 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2023-03-22 | RBC Capital | Reiterate | Outperform |
| 2023-03-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-09-30 | RBC Capital | Maintains | Outperform |
| 2022-09-23 | Jefferies | Maintains | Buy |
| 2022-08-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-13 | RBC Capital | Maintains | Outperform |
| 2022-02-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-13 | Evercore ISI Group | Maintains | Outperform |
| 2021-12-07 | RBC Capital | Maintains | Outperform |
| 2021-10-18 | RBC Capital | Maintains | Outperform |
| 2021-09-14 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-12 | RBC Capital | Initiate | Outperform |